Risk of Immunotherapy Related Toxicity in Patients with Rheumatoid Arthritis

被引：0
|
作者：
Efuni, Elizaveta [1 ]
Cytryn, Samuel [2 ]
Boland, Patrick [2 ]
Sandigursky, Sabina [2 ]
机构：
[1] NYU, Sch Med, New York, NY USA
[2] NYU Langone Hlth, New York, NY USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1339
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Current immunotherapy in rheumatoid arthritis
    Meier, Florian M. P.
    Frerix, Marc
    Hermann, Walter
    Mueller-Ladner, Ulf
    IMMUNOTHERAPY, 2013, 5 (09) : 955 - 974
  • [22] A snapshot of immunotherapy for rheumatoid arthritis
    Albani, S
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2006, 25 (1-2) : 1 - 3
  • [23] SALICYLATE TOXICITY IN ELDERLY PATIENTS WITH RHEUMATOID-ARTHRITIS
    GRIGOR, RR
    SPITZ, PW
    FURST, DE
    JOURNAL OF RHEUMATOLOGY, 1987, 14 (01) : 60 - 66
  • [24] THE INFLUENCE OF CLINICAL AND GENETIC VARIABLES ON METHOTREXATE-RELATED TOXICITY IN PORTUGUESE RHEUMATOID ARTHRITIS PATIENTS
    Lima, A.
    Bernardes, M.
    Monteiro, J.
    Azevedo, R.
    Costa, L.
    Ventura, F.
    Seabra, V.
    Medeiros, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 204 - 204
  • [25] RHEUMATOID-ARTHRITIS - A RISK FACTOR FOR SULFASALAZINE TOXICITY - A METAANALYSIS
    WIJNANDS, MJH
    VANTHOF, MA
    VANDEPUTTE, LBA
    VANRIEL, PLCM
    BRITISH JOURNAL OF RHEUMATOLOGY, 1993, 32 (04): : 313 - 318
  • [26] SERUM CALPROTECTINIS ELEVATED IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS BUT NOT IN PATIENTS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS
    Prajzlerova, K.
    Cerezo, L. Andres
    Hanova, P.
    Mann, H.
    Pavelka, K.
    Vencovsky, J.
    Senolt, L.
    Filkova, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A36 - A36
  • [27] Immunotherapy can ameliorate cardiovascular condition of rheumatoid arthritis patients
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (09) : 2216 - 2216
  • [28] Prostate Cancer Patients with a High Polygenic Risk of Rheumatoid Arthritis have Increased Radiotherapy Toxicity
    McWilliam, A.
    Kerns, S. L.
    Marshall, D. C.
    Azria, D.
    Farcy-Jacquet, M. P.
    Chang-Claude, J.
    Choudhury, A.
    Dunning, A.
    Lambrecht, M.
    Avuzzi, B.
    de Ruysscher, D.
    Seibold, P.
    Sperk, E.
    Talbot, C.
    Vega, A.
    Veldeman, L.
    Webb, A.
    Rancati, T.
    Rosenstein, B. S.
    West, C. M. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S64 - S64
  • [29] Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients
    Benham, Helen
    Nel, Hendrik J.
    Law, Soi Cheng
    Mehdi, Ahmed M.
    Street, Shayna
    Ramnoruth, Nishta
    Pahau, Helen
    Lee, Bernett T.
    Ng, Jennifer
    Brunck, Marion E. G.
    Hyde, Claire
    Trouw, Leendert A.
    Dudek, Nadine L.
    Purcell, Anthony W.
    O'Sullivan, Brendan J.
    Connolly, John E.
    Paul, Sanjoy K.
    Le Cao, Kim-Anh
    Thomas, Ranjeny
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (290)
  • [30] FREQUENCY AND RISK FACTORS FOR THE DEVELOPMENT OF DRUG RELATED PROBLEMS IN HOSPITALIZED PATIENTS WITH RHEUMATOID ARTHRITIS
    Sah, S.
    Ramesh, M.
    VALUE IN HEALTH, 2022, 25 (07) : S492 - S493
12345